Cemacon (CEON RO): BCR transferred part of the debt of Cemacon to an investment fund
BCR has transferred EUR 12 mn out of the total debt owed by Cemacon of EUR 30 mn to an investment fund where the bank is the majority shareholder. This seems to be the first step into the conversion of the debt into equity, which would dilute the stakes owned by the current shareholders. According to the restructuring plan, another EUR 5 mn of would be transferred from CEON?s books to a real-estate vehicle set up by the company.
Antibiotice (ATB RO): Higher sales and net profit in 4Q 2013
4Q 2013 sales have gone up by 12% yoy to RON 100.4 mn, while the net profit reached RON 12.1 mn (vs RON 0.5 mn in 4Q 2012) on lower third party expenses. FY 2013 sales have increased by 4% yoy to RON 317.4 mn, while EBIT has gone up by 23% yoy to RON 51.5 mn. On the other hand ATB had higher financial expenses, up by 79% yoy (RON 16.7 mn), leaving a net profit of RON 28.8 mn, 6% higher yoy.
Bursa de Valori (BVB RO): Increased activity triggered higher sales in 4Q 13
Quarterly sales tripled yoy to RON 10.6 mn, 4Q 13 being the best quarter in recent history with Romgaz IPO and several ABBs; Operating profit for the quarter was RON 4.8 mn, compared to a loss of RON 0.7 mn a year ago; Net financial result was a profit RON 0.6 mn, almost four times higher yoy while net profit for the quarter stood at RON 4.5 mn compared to a loss of RON 0.4 mn in 4Q 12; FY 2013 sales amounted to RON 24.2 mn while net profit stood at RON 10 mn.